Boston Scientific Corporation Spinal Cord Stimulator
Centralized before Judge Josephine L. Staton in the Central District of California in June 2026, the Boston Scientific Spinal Cord Stimulator litigation consolidates federal claims alleging that implanted spinal cord stimulator devices — used to manage chronic pain — caused injury through mechanisms such as lead migration, device malfunction, infection, or complications requiring surgical revision or explantation. With all 29 filed actions currently pending, the docket is fully intact and has not yet lost any claims to early dismissal or resolution, consistent with a proceeding still in its organizational phase.
Implanted medical-device litigation of this kind typically turns on a specific combination of issues once it matures: whether the alleged malfunction reflects a design defect common across a device model (supporting a strong general-causation theory) or a manufacturing or surgical-technique issue specific to individual implants (which fragments the litigation into more individualized causation fights). Which of those two patterns dominates will substantially shape how the JPML's bellwether process is eventually designed and how much of the docket can be resolved on a coordinated basis versus case by case.
Because the docket is only months old, the near-term structural question is less about resolution mechanics and more about scale: how many additional device-related claims are transferred in or newly filed as the litigation becomes more visible to potential plaintiffs and their counsel, which in turn affects how quickly the court moves toward a leadership order and case-management schedule. Criterica Intelligence's platform tracks this early-stage trajectory — claim growth, procedural milestones, and eventual bellwether design — across every active MDL, providing a structural read without projecting a specific causation outcome for this or any individual device claim.
A common design defect across a device model supports a stronger general-causation theory that can be litigated on a coordinated basis, while manufacturing or technique-specific issues tend to fragment the litigation into more individualized causation disputes.
It is in its earliest organizational phase — centralized in June 2026, with all filed actions still pending and no bellwether selection, mature case-management order, or general-causation record established yet.
Volume commonly grows as awareness increases and additional cases are filed or transferred in, which is one of the key early indicators of how large and how long the eventual litigation will run.
No. Structural information describes how the litigation is organized and how similar dockets have progressed — it does not predict any specific claim's causation finding or outcome.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.